Switch View
© Globe Newswire
13.11.2025
ISIN: US0223071020
Alumis, Inc.
ALMS
LISTED
NASDAQ
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Alumis reports third quarter 2025 financial results and highlights recent progress and anticipated milestones including Phase 3 data in early 1Q 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US3207031010
Calidi Biotherapeutics, Inc.
CLDI
LISTED
XASE
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
News Preview
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its third quarter 2025 operating and financial results and rev...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
News Preview
REGULATED INFORMATION...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
13.11.2025
ISIN: US0048901096
Acrivon Therapeutics Inc
ACRV
LISTED
NASDAQ
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancer...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
13.11.2025
ISIN: US68622P1093
Oric Pharmaceuticals Inc
ORIC
LISTED
NASDAQ
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
News Preview
Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: CA31447P1009
Fennec Pharmaceuticals Inc
FRX
LISTED
TSX
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that it intends to offer and sell its common shares in an underwritten registered public offering. In addition, Fennec intends to grant the underwriter...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Perrigo Company plc (PRGO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIA...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US68236X1000
Oncology Institute Inc
TOI
LISTED
NASDAQ
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
News Preview
CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US09077B1044
Bioatla Inc
BCAB
LISTED
NASDAQ
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the third quarter ended September 30, 2025 and provided highli...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US4525253062
ImmuCell Corporation
ICCC
LISTED
NASDAQ
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
News Preview
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial result...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
News Preview
Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US0029421007
Aardvark Therapeutics Inc
AARD
LISTED
NASDAQ
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
News Preview
Q32025 Earnings...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
13.11.2025
ISIN: US76152G1004
Reviva Pharmaceuticals Holdings, Inc.
RVPH
LISTED
NASDAQ
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
– Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – ...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
News Preview
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX).
If you currently own shares of Amylyx Pharmaceuticals stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=22470 for...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON Z...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their OptionsIf you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Changes to the Board of Directors
News Preview
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect....
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partne...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US59935P2092
Milestone Scientific Inc
MLSS
LISTED
XASE
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
News Preview
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 14th, 2025, to discuss the company’s financial results...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US83006G1040
60 Degrees Pharmaceuticals, Inc.
SXTP
LISTED
NASDAQ
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
News Preview
60 Degrees Pharma reports 223% YoY revenue growth in Q3 2025; advances babesiosis programs with Tulane, Mount Sinai, and MUMS canine designation plans....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US09075D1028
BioXyTran, Inc.
BIXT
LISTED
OTC
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
News Preview
BOSTON, MASSACHUSETTS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical-stage biotech company focused on innovative treatments for stroke, Alzheimer’s, and viral infections is pleased to announce the initiation of coverage of its stock by Independent Research, a global equity research firm specializing i...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement
News Preview
13 November 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: FR0012432516
Poxel SA
POXEL
LISTED
EURONEXT
Poxel Reports Revenue for the Third Quarter 2025
News Preview
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today reports its revenue for the quarter ended Septe...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
CSE Bulletin: MOC Eligibility Update
News Preview
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date BIOV...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
San Francisco, California--(Newsfile Corp. - November 13, 2025) - A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly anticipated tre...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US97382D3035
Windtree Therapeutics Inc
WINT
LISTED
NASDAQ
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
News Preview
Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans that can power real shifts in health outcome...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: US59045L2051
Mersana Therapeutics, Inc.
MRSN
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Nov. 13, 2025 /PRNewswire/ -- The Ademi Firm is investigating Mersana (NASDAQ: MRSN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Day One Biopharmaceuticals....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US74340E1038
Progyny Inc
PGNY
LISTED
NASDAQ
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
News Preview
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 3:00 p.m. GMT / 10:0...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: CA58469E4085
Medicure Inc.
MPH
LISTED
TSX
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
News Preview
WINNIPEG, MB / ACCESS Newswire / November 13, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarte...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares – October 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Completes Acquisition of Metsera
News Preview
Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
“This strategic milestone represents more than a transaction—it's a deliberate investment in the f...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
News Preview
31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
More than 500 Unhoused Angelenos to find Housing and Get Medical, Behavioral Health and other Services thanks to $2 Million Investment by Health Net in LA Family Housing
News Preview
This funding opens doors for hundreds of Angelenos to move into safe, stable homes.
LOS ANGELES, Nov. 13, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), awarded a renewal of a $1 million grant...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US29415J1060
enVVeno Medical Corporation
NVNO
LISTED
NASDAQ
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
News Preview
IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it has received an unfavorable decision from the U.S. Food & Drug Administration ("FDA") i...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
News Preview
Management to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - plans to host a webinar at 5:00 PM Eastern Time...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
News Preview
LOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - announced that co-founder of eXoZymes, Tyler Korman, PhD, has taken on the role of Chief Scientific Officer, while Amy L...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US88066N3035
Tenon Medical, Inc.
TNON
LISTED
NASDAQ
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
News Preview
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~~ SImmetry®+ alpha launch in Q4 2025 advances strategic portfolio ~~ Foundation set for sustained growth through portfolio diversificati...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
News Preview
– NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ: ALVO) concerning possible violations of federal securities laws.On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete R...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
News Preview
ALVO Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- Shareholder rights firm Hagens Berman is scrutinizing Icelandic biopharmaceutical company Alvotech (NASDAQ: ALVO) over the propriety of its disclosures regarding its lead drug candidate and...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Investors Urged to Contact Levi & Korsinsky for Information Before January 5, 2026 - Inspire Medical Systems, Inc. (INSP)
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=17...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US45256X1037
Immunitybio Inc
IBRX
LISTED
NASDAQ
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations
News Preview
A new U.S. survey conducted by The Harris Poll on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) reveals that many people living with non-muscle invasive bladder cancer (NMIBC) feel left out of critical treatment conversations. Fewer than one in five patients surveyed (18%) report their healthcare providers (HCPs) discuss all available treatment optio...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
News Preview
Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequen...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter -- Hagens Berman
News Preview
Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA rejectio...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
NRC Health Partners with BJC HealthCare to Advance Experience Excellence Across a Unified Network
News Preview
NRC Health, the leader in healthcare experience management, is proud to announce a new partnership with BJC Health System, one of the nation’s largest nonprofit integrated healthcare delivery organizations. The collaboration will unify and elevate patient and employee experiences across BJC’s hospitals, clinics, and academic partners, reinforcing...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US1710774076
Niagen Bioscience Inc
CDXC
LISTED
NASDAQ
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
News Preview
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen® Beauty, the first-ever beauty supplement in the US featuring Niagen (patented nicotinamide riboside or NR) — the most efficient, effective, and high quality...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™
News Preview
As a leader in migraine treatment, AbbVie is committed to addressing the impact of migraine in the workplace.
2025 honorees represent a diverse group of achievers—from teachers and authors to small business owners and aspiring yoga an...
Themefolio
Profiler
Peergroup
© ActuNews
13.11.2025
ISIN: FR0000061129
Boiron SA
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 31 octobre 2025
News Preview
Le 12 novembre 2025
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre total de d...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from a retrospective analysis conducted by researchers at the University of Tubingen, Germany. The study, titled “Characterization of long...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial
News Preview
Gilead Sciences, Inc. (NASDAQ: GILD) today announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who are virologically suppressed switching from a multi-tablet regimen to an investigational single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Surpasses 100,000 Pounds of Collected Medication in Year Seven of Annual “Crush the Crisis”
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 19,846 pounds, approximately 13.6 million doses, of unused or expired medications during its seventh annual “Crush the Crisis” national prescription drug take back day. In total, the organization has now collected more than 108,500...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
News Preview
Lead Plaintiff Deadline is January 9, 2026
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix") American Depositary Shares ("ADS") that a secur...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
News Preview
Lead Plaintiff Deadline is January 5, 2026
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors in Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire") that a securities class action has been filed on behalf o...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Class Action Lawsuit Filed: Baxter International, Inc. (BAX) - Join by December 15, 2025 - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=177135...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
News Preview
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will participate in the Canaccord Genuity MedTech, Diagnostics and Digit...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
